Literature DB >> 9083928

Why do some females reject males? The molecular basis for male-specific graft rejection.

D M Scott1, I E Ehrmann, P S Ellis, P R Chandler, E Simpson.   

Abstract

The male-specific minor histocompatibility antigen H-Y plays an important role in both graft rejection and graft-versus-host disease following transplantation of male tissue into females that are completely matched at the major histocompatibility loci. The recent identification of two peptides that, in association with the mouse H-2Kk or human HLA B7 major histocompatibility class I molecules, are recognised by H-Y-specific T cells, has provided evidence for the molecular basis for such anti-H-Y responses. These peptides are encoded by the mouse and human homologues of a ubiquitously expressed Y chromosome gene, Smcy, whilst the equivalent peptides encoded by the X chromosome homologues of this gene fail to be recognised. Genetic studies have demonstrated that, as is the case for other minor histocompatibility antigens, peptide epitopes from several closely linked genes may be required to interact in order to elicit a response against H-Y. Definition of the peptides and the genes that encode these epitopes will allow the development of tolerogenic protocols that could specifically down-modulate the response to H-Y and perhaps even other minor histocompatibility antigens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083928     DOI: 10.1007/s001090050095

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  14 in total

Review 1.  Donor-Specific Antibodies in Kidney Transplant Recipients.

Authors:  Rubin Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-26       Impact factor: 8.237

2.  The impact of donor and recipient weight incompatibility on renal transplant outcomes.

Authors:  Limy Wong; Aileen Counihan; Patrick O'Kelly; Donal J Sexton; Conall M O'Seaghdha; Colm Magee; Dilly Little; Peter J Conlon
Journal:  Int Urol Nephrol       Date:  2017-11-14       Impact factor: 2.370

3.  AIP1 prevents graft arteriosclerosis by inhibiting interferon-γ-dependent smooth muscle cell proliferation and intimal expansion.

Authors:  Luyang Yu; Lingfeng Qin; Haifeng Zhang; Yun He; Hong Chen; Jordan S Pober; George Tellides; Wang Min
Journal:  Circ Res       Date:  2011-06-23       Impact factor: 17.367

Review 4.  Glial grafting for demyelinating disease.

Authors:  V Tepavcević; W F Blakemore
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 5.  Essential concept of transplant immunology for clinical practice.

Authors:  Damodar Kumbala; Rubin Zhang
Journal:  World J Transplant       Date:  2013-12-24

Review 6.  AIP1 in graft arteriosclerosis.

Authors:  Wang Min; Jordan S Pober
Journal:  Trends Cardiovasc Med       Date:  2011-11       Impact factor: 6.677

7.  Mouse models for graft arteriosclerosis.

Authors:  Lingfeng Qin; Luyang Yu; Wang Min
Journal:  J Vis Exp       Date:  2013-05-14       Impact factor: 1.355

8.  Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches.

Authors:  Terry J Fry; Jessica L Shand; Matthew Milliron; Sarah K Tasian; Crystal L Mackall
Journal:  Cancer Immunol Immunother       Date:  2009-01-13       Impact factor: 6.968

9.  Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.

Authors:  Sabrina M Hess; Ellen F Young; Keith R Miller; Benjamin G Vincent; Adam S Buntzman; Edward J Collins; Jeffrey A Frelinger; Paul R Hess
Journal:  Transpl Immunol       Date:  2013-10-23       Impact factor: 1.708

10.  Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model.

Authors:  Ashlee E Watts; Amy E Yeager; Oleg V Kopyov; Alan J Nixon
Journal:  Stem Cell Res Ther       Date:  2011-01-27       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.